◆ 会议时间：2025年6月24-27日
◆ 会议地点：美国 波士顿

◆ 会议简介：

2025年第25届临床免疫学会联合会(FOCIS)年会将于2025年6月24-27日在美国波士顿举行。FOICS年会是一个聚焦转化免疫学的会议！上届会议有来自30多个国家和地区的近千名代表出席。

临床免疫学会联合会(FOCIS)最初是作为一个跨学科的会议而建立，并于2001年举行了第一次年会，在连续两次成功的会议之后，FOCIS在2003年作为非营利组织正式成立。FOCIS现包括59个会员学会，代表大约65000名临床医生。FOCIS致力于宣促进跨学科的认识与治疗基于免疫系统疾病的方法，通过免疫学来改善人类健康。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

FOCIS 2025 - 25th Annual Meeting of the Federation of Clinical Immunology Societies

Date: June 24-27, 2025
Venue: Boston Marriott Copley Place, Boston, Massachusetts, USA, USA

What makes FOCIS truly unique is our interdisciplinary approach to immunology. Translational researchers play a key role in breaking down the silos that currently limit bench to bedside to bench methodology.

The FOCIS Annual Meeting is an incubator for developing scientists and clinicians to coalesce with relevant biotech and pharmaceutical industries to improve the field of translational research throughout medicine.

摘要征文投稿：

Key Dates

• Opening of Abstract Submission
  Wednesday, October 23, 2024 
• Deadline for Abstract Submission
  Wednesday, January 15, 2025
• Notification of Abstract Acceptance Sent to Presenting Authors
  Week of March 24, 2025
• Registration Deadline for Presenting Authors
  Friday, April 4, 2025 

点此提交摘要>>>Submit Abstract>>>

Abstract Title: The first letter of all major words should be capitalized (excludes: the, at, and, etc.), with no punctuation at the end. No word count limit.

Presentation Type: Select preference for oral, poster or either.

Author Information: The presenting author must submit the abstract and will receive confirmation and acceptance notice. Co-authors may be added. Each co-author requires first name, last name, email address, institution name, city, state, and country. Co-authors must be ordered as they should appear in the program.

Subject Areas: Select areas such as abstract topic, basis of research, and FOCIS pillar.

Abstract Text: Limited to 250-word count. Graphic elements, such as charts, pictures, etc. may not be included in abstract submission.

Disclosure Form: Presenting author must complete a disclosure form. Form requires acceptance of presentation statement, disclosure of financial relationships, and resolution of conflicts of interest, in accordance with FOCIS policy.

Published Content: Abstracts that have been or will be published prior to the time of presentation at the Annual Meeting may not be submitted. Exception: If additional data/research is added to a previously published abstract, the abstract may be submitted.

Submission Fee: There is a $30 non-refundable submission fee per abstract. This fee is waived for presenting authors who are FOCIS members.

Selection and Presentation
Each abstract is blinded and peer-reviewed by three members of the Abstract Review Committee.
Accepted abstracts will be selected as either a short oral presentation, poster presentation, or rejected. Oral presentations are placed into the FOCIS 2025 program on Wednesday, Thursday, or Friday afternoon. Oral presentations are allotted a maximum of 15 minutes, with 10 minutes for presentation and an additional 5 minutes allotted for questions and discussion.
Notification

If the abstract is accepted by the reviewers, the presenting author will receive an abstract acceptance notification. Notifications of acceptance or rejection will be sent the week of March 24, 2025 to the presenting author.

Registration Policy
Presenting authors of accepted abstracts must register for the FOCIS Annual Meeting by April 4, 2025.
Upon payment of the FOCIS Annual Meeting registration fee, the abstract will be confirmed and scheduled into the program.

Abstracts accepted for presentation but not registered by the deadlines will be withdrawn and will not be included in the scientific program or abstract supplement.

Abstract Publishing
Accepted abstracts are published in our Abstract Supplement, which is a PDF file available on the FOCIS website. This is published in early June and is available to the public.

注册费：

FOCIS 2025 Annual Meeting Registration Rates

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。